Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chambers

Showing results (431-440 of 520) with videos related to

Pageof 52
Sort By:
Cancer Research|January 19, 1999
CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxisY U Katagiri, J Sleeman, H Fujii, et al.
Molecular Cancer|January 18, 2007
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activationRajeev S Samant, David W Clark, Rebecca A Fillmore, et al.
Cancer Biology & Therapy|November 1, 2005
Expression of osteopontin and HGF/met in adult soft tissue tumorsVivien H C Bramwell, Alan B Tuck, Sylvia M Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2004
Origins of community strains of methicillin-resistant Staphylococcus aureusEdwin D Charlebois, Françoise Perdreau-Remington, Barry Kreiswirth, et al.
The Journal of Infectious Diseases|July 1, 1987
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditionsJ L Gerberding, C E Bryant-LeBlanc, K Nelson, et al.
British Journal of Cancer|August 9, 2012
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment responseJ W Thoms, A Dal Pra, P H Anborgh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
The Future Ain't What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group InnovationsScott R Evans, Robin Patel, Toshimitsu Hamasaki, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 12, 2010
Human 21T breast epithelial cell lines mimic breast cancer progression in vivo and in vitro and show stage-specific gene expression patternsLesley H Souter, Joseph D Andrews, Guihua Zhang, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2017
Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureusYuki Katayama, Takuya Azechi, Motoyasu Miyazaki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
Pageof 52

Showing results (431-440 of 520) with videos related to

Sort By:
Pageof 52
Cancer Research|January 19, 1999
CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxisY U Katagiri, J Sleeman, H Fujii, et al.
Molecular Cancer|January 18, 2007
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activationRajeev S Samant, David W Clark, Rebecca A Fillmore, et al.
Cancer Biology & Therapy|November 1, 2005
Expression of osteopontin and HGF/met in adult soft tissue tumorsVivien H C Bramwell, Alan B Tuck, Sylvia M Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2004
Origins of community strains of methicillin-resistant Staphylococcus aureusEdwin D Charlebois, Françoise Perdreau-Remington, Barry Kreiswirth, et al.
The Journal of Infectious Diseases|July 1, 1987
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditionsJ L Gerberding, C E Bryant-LeBlanc, K Nelson, et al.
British Journal of Cancer|August 9, 2012
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment responseJ W Thoms, A Dal Pra, P H Anborgh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
The Future Ain't What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group InnovationsScott R Evans, Robin Patel, Toshimitsu Hamasaki, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 12, 2010
Human 21T breast epithelial cell lines mimic breast cancer progression in vivo and in vitro and show stage-specific gene expression patternsLesley H Souter, Joseph D Andrews, Guihua Zhang, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2017
Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureusYuki Katayama, Takuya Azechi, Motoyasu Miyazaki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
Pageof 52